If the IV admixture has already been infused into the patient by the time the QA Pharmacist knows the results from the contamination test, why bother?
Regular use of Q.I. Medical end-product testers is intended to confirm that aseptic technique is being maintained. Since it is impractical to test, quarantine, and then release every admixture, the supervising pharmacist must watch for trends in the contamination testing program. If several tests exhibit turbidity over a short period of time, it would trigger an investigation. An occasional positive would probably be tolerated. The supervisor would check to see if the occasional positives were prepared by the same pharmacist or technician. The point is to watch for trends and the detection of problems in validated procedures.
Related Questions
- If the IV admixture has already been infused into the patient by the time the QA Pharmacist knows the results from the contamination test, why bother?
- What amount of time can the Connector Luer Lock (C35 or C45) safely stay on the patient’s IV line?
- What amount of time can the Connector safely stay on the patient’s IV line?
